Heng Fai Ambrose Chan sold $2.9M of IBO
director, owner at IMPACT BIOMEDICAL INC.. 2,526,918 shares at an average of $1.15, traded Mar 31, 2025, filed Apr 2, 2025.
Score components
- +15RoleDirector
- +25Trade size$2.9M at market
- +20Share of holdings soldSold 100% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001641172-25-002479, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 31, 2025 | SOpen-market sale Common Stockindirect: See footnote | -300,000 | $1.03 | $308k | 1,253,904 | Apr 2, 2025 |
| Apr 1, 2025 | SOpen-market sale Common stockindirect: See footnote | -400,000 | $0.98 | $393k | 853,904 | Apr 2, 2025 |
| Apr 1, 2025 | SOpen-market sale Common Stockindirect: See footnote | -650,000 | $1.45 | $941k | 1,910,976 | Apr 2, 2025 |
| Apr 1, 2025 | SOpen-market sale Common Stockindirect: See footnote | -1,176,918 | $1.08 | $1.3M | 734,058 | Apr 2, 2025 |
Related signals
Other insiders at IMPACT BIOMEDICAL INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 12Weak | IBOsell IMPACT BIOMEDICAL INC. | Dss, Inc. owner | $1,686 906 shares | -0% | |
| 41Moderate | IBOsell IMPACT BIOMEDICAL INC. | Dss, Inc. owner | $88k 161,000 shares | -100% | |
| 54Moderate | IMPACT BIOMEDICAL INC. | Heng Fai Ambrose Chan director | $174k 351,555 shares | -100% | |
| 63Notable | IMPACT BIOMEDICAL INC. | Dss, Inc. owner | $845k 890,800 shares | -85% | |
| 68Notable | IMPACT BIOMEDICAL INC. | Heng Fai Ambrose Chan director, owner | $1.1M 1,689,693 shares | -198% | |
| 65Notable | IMPACT BIOMEDICAL INC. | Dss, Inc. owner | $2.0M 605,620 shares | -364% | |
| 2Weak | IBObuy IMPACT BIOMEDICAL INC. | Dss, Inc. owner | $310 200 shares | +0% | |
| 45Moderate | IBOsell IMPACT BIOMEDICAL INC. | Dss, Inc. owner | $249k 53,300 shares | -100% | |
| 25Weak | IBObuy IMPACT BIOMEDICAL INC. | Frank D Heuszel Chief Executive Officer | $1,129 500 shares | +1% | |
| 25Weak | IBObuy IMPACT BIOMEDICAL INC. | Frank D Heuszel Chief Executive Officer | $2,739 1,050 shares | +1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.